Search research articles
Contact Us
Filters
Showing results (541-550 of 563) with videos related to
Page
of 57
Sort By:
Gastroenterology
|
November 3, 2015
Association Between Response to Etrolizumab and Expression of Integrin αE and Granzyme A in Colon Biopsies of Patients With Ulcerative Colitis
Gaik W Tew, Jason A Hackney, Deena Gibbons, et al.
Gut
|
April 27, 2021
Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD
Nicholas A Kennedy, Simeng Lin, James R Goodhand, et al.
Journal of Crohn'S & Colitis
|
September 2, 2021
Adalimumab and Infliximab Impair SARS-CoV-2 Antibody Responses: Results from a Therapeutic Drug Monitoring Study in 11 422 Biologic-Treated Patients
Neil Chanchlani, Simeng Lin, Desmond Chee, et al.
Alimentary Pharmacology & Therapeutics
|
October 7, 2014
Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients
N A Kennedy, R Kalla, B Warner, et al.
Gut
|
February 8, 2023
Considerations for peripheral blood transport and storage during large-scale multicentre metabolome research
James L Alexander, Nicola J Wyatt, Stephane Camuzeaux, et al.
Journal of Crohn'S & Colitis
|
June 5, 2020
Clinical Features and Genetic Risk of Demyelination Following Anti-TNF Treatment
Simeng Lin, Harry D Green, Peter Hendy, et al.
The Lancet. Gastroenterology & Hepatology
|
March 3, 2019
Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study
Nicholas A Kennedy, Graham A Heap, Harry D Green, et al.
Journal of Crohn'S & Colitis
|
December 28, 2018
Current Practices in Ileal Pouch Surveillance for Patients With Ulcerative Colitis: A Multinational, Retrospective Cohort Study
Mark A Samaan, Katrina Forsyth, Jonathan P Segal, et al.
The Lancet. Gastroenterology & Hepatology
|
February 10, 2024
Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn's disease (ASTIClite): an open-label, multicentre, randomised controlled trial
James O Lindsay, Daniel Hind, Lizzie Swaby, et al.
The Lancet. Gastroenterology & Hepatology
|
February 6, 2022
COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study
James L Alexander, Nicholas A Kennedy, Hajir Ibraheim, et al.
Page
of 57
Search research articles
Search
Showing results (541-550 of 563) with videos related to
Sort By:
Page
of 57
Gastroenterology
|
November 3, 2015
Association Between Response to Etrolizumab and Expression of Integrin αE and Granzyme A in Colon Biopsies of Patients With Ulcerative Colitis
Gaik W Tew, Jason A Hackney, Deena Gibbons, et al.
Gut
|
April 27, 2021
Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD
Nicholas A Kennedy, Simeng Lin, James R Goodhand, et al.
Journal of Crohn'S & Colitis
|
September 2, 2021
Adalimumab and Infliximab Impair SARS-CoV-2 Antibody Responses: Results from a Therapeutic Drug Monitoring Study in 11 422 Biologic-Treated Patients
Neil Chanchlani, Simeng Lin, Desmond Chee, et al.
Alimentary Pharmacology & Therapeutics
|
October 7, 2014
Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients
N A Kennedy, R Kalla, B Warner, et al.
Gut
|
February 8, 2023
Considerations for peripheral blood transport and storage during large-scale multicentre metabolome research
James L Alexander, Nicola J Wyatt, Stephane Camuzeaux, et al.
Journal of Crohn'S & Colitis
|
June 5, 2020
Clinical Features and Genetic Risk of Demyelination Following Anti-TNF Treatment
Simeng Lin, Harry D Green, Peter Hendy, et al.
The Lancet. Gastroenterology & Hepatology
|
March 3, 2019
Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study
Nicholas A Kennedy, Graham A Heap, Harry D Green, et al.
Journal of Crohn'S & Colitis
|
December 28, 2018
Current Practices in Ileal Pouch Surveillance for Patients With Ulcerative Colitis: A Multinational, Retrospective Cohort Study
Mark A Samaan, Katrina Forsyth, Jonathan P Segal, et al.
The Lancet. Gastroenterology & Hepatology
|
February 10, 2024
Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn's disease (ASTIClite): an open-label, multicentre, randomised controlled trial
James O Lindsay, Daniel Hind, Lizzie Swaby, et al.
The Lancet. Gastroenterology & Hepatology
|
February 6, 2022
COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study
James L Alexander, Nicholas A Kennedy, Hajir Ibraheim, et al.
Page
of 57